Perspective Therapeutics cut to sector perform from outperform by RBC; target lowered to $4 from $14
CATX•RBC cut Perspective Therapeutics to sector perform from outperform and lowered its target price to $4 from $14.
Related News
Rosenblatt Securities raises RingCentral target price to $105 from $80
RNG•
Blackstone: BMO raises target price to $140 from $130
BX•
Logan Energy to be acquired by Ovintiv for $1.40 per share, with Logan Oil spin-out
OVV•
Alliance Resource Partners Q3 profit jumps on record royalty revenues
ARLP•
Snap-on cuts target price to $405 from $435
SNA•